Advancing science, assessing long-term performance

As a national leader in implantable pain management systems, Nura physicians and researchers often work with medical device companies to study the long-term performance of specific devices.

Nura Research Studies

Safety of Interlaminar Cervical Epidural Injections: Experience With 12,168 Procedures in a Single Pain Clinic as seen in Pain Physician Journal

View Research Study

 

 

 

 

Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study as seen in Neuromodulation Journal

View Research Study

 

 

 

Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry as seen in Neuromodulation Journal

View Research Study

Medical articles by Nura physicians

Neurostimulation for Chronic Pain by David Schultz, MD in Minnesota Physician, February 2022

Cancer Pain Management by R. Scott Stayner, MD, PhD in Minnesota Physician, August 2021

The MinuteMan – Advances in Spinal Fusion by R. Scott Stayner, MD, PhD in Minnesota Physician, April 2021

Targeted Drug Delivery – Feedback from Patients by David Schultz, MD in Minnesota Physician, May 2020

Dialing Down Opioid Use – Alternative Treatments by David Schultz, MD in Minnesota Physician, April 2019

The Importance of a Pain Management Plan – A Guide for Primary Care Physicians by David Schultz, MD in Minnesota Physician, November 2015

Clinical abstracts & posters

A Comparison of Pain Relief from Spinal Cord Stimulation between Patients with and without Failed Back Surgery Syndrome by R. Scott Stayner, MD, PhD at INS 2022

Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain Results of a Single-Center Survey Study by David Schultz, MD at CNS 2022

Dorsal Root Ganglion Stimulation Reduces Pain and Improves Physical Function for Causalgia Patients by David Schultz, MD at NANS 2022

DRG Stimulation is an Effective Treatment for Patients with Causalgia of the Lower Extremities by David Schultz, MD at NANS 2022

Current clinical trials

Abbott: Spinal Cord Stimulator (SCS) and Dorsal Root Ganglion (DRG) Systems

• REALITY: Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator: NCT03876054
• PROLONG: Prospective, Multi-center, Open-label, Post-market Study: NCT03908476
• TARGET: A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs due to CRPS Type I and II: NCT02800863

Medtronic: Targeted Drug Delivery Systems and Neurostimulator Systems

• PSR: Product Surveillance Registry: NCT01524276
• ECHO-MAC: Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study: NCT04765735

You could be the one

Find out how you could help advance medicine. Call 952-937-9000 or send an email to research@nuraclinics.com to learn more about participating!